These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 1347278)

  • 21. Double-blind randomized trial of bismuth subsalicylate and clindamycin for treatment of Helicobacter pylori infection.
    Westblom TU; Madan E; Subik MA; Duriex DE; Midkiff BR
    Scand J Gastroenterol; 1992; 27(3):249-52. PubMed ID: 1502490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An alternative non-macrolide, non-imidazole treatment regimen for curing Helicobacter pylori and duodenal ulcers: ranitidine bismuth citrate plus amoxicillin. The RBC H. pylori Study Group.
    Graham DY; Breiter JR; Ciociola AA; Sykes DL; McSorley DJ
    Helicobacter; 1998 Jun; 3(2):125-31. PubMed ID: 9631312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized, controlled study.
    Saberi-Firoozi M; Massarrat S; Zare S; Fattahi M; Javan A; Etaati H; Dehbashi N
    Am J Gastroenterol; 1995 Sep; 90(9):1419-23. PubMed ID: 7661161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of intragastric acidity on Helicobacter pylori eradication with bismuth-metronidazole-amoxicillin.
    Chang CS; Yang CY; Wong FN; Chen GH; Lien HC; Yeh HZ; Poon SK
    Hepatogastroenterology; 1999; 46(28):2713-7. PubMed ID: 10522070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of acid suppression and bismuth medications on the performance of diagnostic tests for Helicobacter pylori infection.
    Bravo LE; Realpe JL; Campo C; Mera R; Correa P
    Am J Gastroenterol; 1999 Sep; 94(9):2380-3. PubMed ID: 10483995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colloidal bismuth subcitrate, ranitidine, and ranitidine plus metronidazole in the treatment of duodenal ulcer and Helicobacter pylori infection: a controlled and prospective study.
    Huang CK; Chen GH
    Zhonghua Yi Xue Za Zhi (Taipei); 1993 Jul; 52(1):15-20. PubMed ID: 8364776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maintenance therapy with colloidal bismuth subcitrate reduces duodenal ulcer relapse.
    Bardhan KD; Singh S; Morris P; Thompson M; Hinchliffe RF; Cary BA; Wall RM; Blakemore CB
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):128-34. PubMed ID: 9646192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
    Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
    Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HELIDAC therapy (bismuth subsalicylate/metronidazole/tetracycline hydrochloride).
    Claussen DW
    Gastroenterol Nurs; 1997; 20(5):188-9. PubMed ID: 9384064
    [No Abstract]   [Full Text] [Related]  

  • 30. Short and long term outcome of Helicobacter pylori positive resistant duodenal ulcers treated with colloidal bismuth subcitrate plus antibiotics or sucralfate alone.
    Bianchi Porro G; Parente F; Lazzaroni M
    Gut; 1993 Apr; 34(4):466-9. PubMed ID: 8491391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guidelines for the treatment of Helicobacter pylori in the pediatric population.
    Robinson DM; Abdel-Rahman SM; Nahata MC
    Ann Pharmacother; 1997 Oct; 31(10):1247-9. PubMed ID: 9337451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective, randomized, investigator-blind trial of Helicobacter pylori infection treatment in patients with refractory duodenal ulcers. Healing and long-term relapse rates.
    Mantzaris GJ; Hatzis A; Tamvakologos G; Petraki K; Spiliades C; Triadaphyllou G
    Dig Dis Sci; 1993 Jun; 38(6):1132-6. PubMed ID: 8508709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
    Labenz J; Stolte M; Peitz U; Tillenburg B; Köhl H; Becker T; Börsch G
    Z Gastroenterol; 1995 Oct; 33(10):590-3. PubMed ID: 7502551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Helicobacter pylori infection in childhood: results of management with ranitidine bismuth citrate plus amoxicillin and tinidazole.
    Nijevitch AA; Farztdinov KM; Sataev VU; Khasanov RSh ; Katayev VA; Khusnutdinov SM; Akhunov ED; Kazykhanov NS
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1243-50. PubMed ID: 11129216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ranitidine bismuth citrate therapy.
    Harris A; Misiewicz JJ
    Aliment Pharmacol Ther; 1996 Dec; 10(6):1035. PubMed ID: 8971307
    [No Abstract]   [Full Text] [Related]  

  • 36. Azithromycin triple therapy for Helicobacter pylori infection: azithromycin, tetracycline, and bismuth.
    al-Assi MT; Genta RM; Karttunen TJ; Cole RA; Graham DY
    Am J Gastroenterol; 1995 Mar; 90(3):403-5. PubMed ID: 7872278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Addition of bismuth subsalicylate to triple eradication therapy for Helicobacter pylori infection: efficiency and adverse events].
    Hinostroza Morales D; Díaz Ferrer J
    Rev Gastroenterol Peru; 2014; 34(4):315-20. PubMed ID: 25594755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastroduodenal mucosal prostaglandin generation in patients with Helicobacter pylori before and after treatment with bismuth subsalicylate.
    Avunduk C; Suliman M; Gang D; Polakowski N; Eastwood GL
    Dig Dis Sci; 1991 Apr; 36(4):431-4. PubMed ID: 2007360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer.
    Hentschel E; Brandstätter G; Dragosics B; Hirschl AM; Nemec H; Schütze K; Taufer M; Wurzer H
    N Engl J Med; 1993 Feb; 328(5):308-12. PubMed ID: 8419816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ranitidine bismuth citrate in the treatment of Helicobacter pylori infection and duodenal ulcer.
    Vondracek TG
    Ann Pharmacother; 1998 Jun; 32(6):672-9. PubMed ID: 9640487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.